ScoreWhy is Bristol Myers Squibb Co. ?
1
Healthy long term growth as Net Sales has grown by an annual rate of 6.47% and Operating profit at 23.31%
2
The company has declared positive results in Mar'2025 after 4 consecutive negative quarters
- OPERATING CASH FLOW(Y) Highest at USD 15,901 MM
- ROCE(HY) Highest at 29.31%
- DIVIDEND PER SHARE(HY) Highest at USD 3.15
3
With ROCE of 19.69%, it has a fair valuation with a 3.08 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -9.62%, its profits have risen by 1.8% ; the PEG ratio of the company is 10.5
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -9.62% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Bristol Myers Squibb Co. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Bristol Myers Squibb Co. for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Bristol Myers Squibb Co.
36.16%
0.70
29.05%
S&P 500
16.0%
0.70
20.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.83%
EBIT Growth (5y)
24.18%
EBIT to Interest (avg)
5.76
Debt to EBITDA (avg)
1.96
Net Debt to Equity (avg)
2.19
Sales to Capital Employed (avg)
0.73
Tax Ratio
10.99%
Dividend Payout Ratio
71.98%
Pledged Shares
0
Institutional Holding
84.14%
ROCE (avg)
13.51%
ROE (avg)
33.03%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
8.68
EV to EBIT
12.62
EV to EBITDA
10.52
EV to Capital Employed
3.67
EV to Sales
3.96
PEG Ratio
0.33
Dividend Yield
48.46%
ROCE (Latest)
29.09%
ROE (Latest)
65.61%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
ROCE(HY)
Highest at 46.7%
DIVIDEND PER SHARE(HY)
Highest at USD 3.5
INTEREST COVERAGE RATIO(Q)
Highest at 1,299.51
DEBT-EQUITY RATIO
(HY)
Lowest at 152.27 %
DEBTORS TURNOVER RATIO(HY)
Highest at 3.5 times
NET SALES(Q)
Highest at USD 12,982 MM
OPERATING PROFIT(Q)
Highest at USD 5,289 MM
OPERATING PROFIT MARGIN(Q)
Highest at 40.74 %
PRE-TAX PROFIT(Q)
Highest at USD 4,749 MM
NET PROFIT(Q)
Highest at USD 3,855.06 MM
EPS(Q)
Highest at USD 1.62
-2What is not working for the Company
DIVIDEND PAYOUT RATIO(Y)
Lowest at 38.9%
RAW MATERIAL COST(Y)
Grown by 6.87% (YoY
Here's what is working for Bristol Myers Squibb Co.
Interest Coverage Ratio
Highest at 1,299.51
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Dividend per share
Highest at USD 3.5 and Grown
In each year in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (USD)
Net Sales
Highest at USD 12,982 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 5,289 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 40.74 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 4,749 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 3,855.06 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 1.62
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Lowest at 152.27 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 3.5 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Bristol Myers Squibb Co.
Dividend Payout Ratio
Lowest at 38.9%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
Raw Material Cost
Grown by 6.87% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
